State Of New Jersey Common Pension Fund D Novavax Inc Transaction History

State Of New Jersey Common Pension Fund D

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$18.2 - $76.12 $338,829 - $1.42 Million	18,617 Added 39.58%	65,648 $1.2 Million
Q2 2022 Aug 04, 2022	BUY	$36.28 - $75.29 $125,347 - $260,126	3,455 Added 7.93%	47,031 $2.42 Million
Q1 2022 May 03, 2022	BUY	$69.73 - $142.9 $119,726 - $245,359	1,717 Added 4.1%	43,576 $3.21 Million
Q4 2021 Jan 31, 2022	BUY	$134.56 - $217.97 $20,722 - $33,567	154 Added 0.37%	41,859 $5.99 Million
Q3 2021 Oct 27, 2021	SELL	$177.8 - $270.58 $42,138 - $64,127	-237 Reduced 0.57%	41,705 $8.65 Million
Q2 2021 Jul 23, 2021	BUY	$121.0 - $257.67 $477,103 - $1.02 Million	3,943 Added 10.38%	41,942 $8.91 Million
Q1 2021 Apr 27, 2021	BUY	$112.98 - $319.93 $182,575 - $517,006	1,616 Added 4.44%	37,999 $6.89 Million
Q4 2020 Feb 03, 2021	SELL	$78.74 - $139.5 $148,346 - $262,818	-1,884 Reduced 4.92%	36,383 $4.06 Million
Q3 2020 Oct 27, 2020	BUY	$79.44 - $178.51 $195,740 - $439,848	2,464 Added 6.88%	38,267 $4.15 Million
Q2 2020 Aug 04, 2020	BUY	$13.86 - $83.61 $496,229 - $2.99 Million	35,803 New	35,803 $2.98 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.